- The Canadian military have started an investigation into reports thatthe controversial antimalarial Lariam (mefloquine) from Roche may be behind reports of aggressive behavior by Canadian and American peace-keeping forces in Somalia, reports the Ottawa Citizen. At the center of the enquiry are the deaths of two Somali teenagers, allegedly killed by members of the Canadian Airborne Regiment. In the UK, almost 1,000 people have joined a class action suit against Roche, citing side effects from taking mefloquine.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze